Intervention
Our 32-page EB booklet contained content previously identi ed by experts as essential to informed decisionmaking about PSA screening. [1] [2] [3] [4] 16, 17 We included quantitative data 1, 18 and maximised the readability of the booklet. 19 After pilot testing, the nal version of our EB booklet comprised 3085 words (Flesch-Kincaid grade level = 7.3). The comparison pamphlet had been published by the Australian government to advise men of agreed policy 1 about PSA screening (968 words; Flesch-Kincaid grade level = 11.2). It was non-numerical and shorter.
Pre-and post-test measures
Men's estimates of lifetime risks (0-74 years) of developing and dying from prostate cancer, 7, 20 level of worry, interest in having a screening PSA test within the next 12 months 21 and perceived ability to make an informed choice 9 were assessed. Ten true/false items 8, 22 assessed knowledge, and the total percentage of correct responses was computed to yield a composite score.
By adapting an attitudinal measure about mammography screening, 23 we asked men to indicate their strength of agreement with reasons for (n=3) and against (n=2) PSA screening. Positive scores indicated views for PSA screening and negative scores indicated a view against.
At post-test, we repeated these measures and included the three-item Decisional Uncertainty subscale of the Decisional Con ict Scale and the nine-item Factors Contributing to Uncertainty scale to assess decisional con ict. 9 Eleven questions assessed the acceptability of the information the men had received. 24 Demographic characteristics, symptoms in the lower urinary tract, 25 previous uptake of PSA screening and men's preferred role in medical decision-making ("passive", "collaborative" or "active") 26 were also assessed at pre-test.
Statistical analysis
Our study was powered to detect a mean difference of 0.35 between groups in decisional con ict scores (b=0.80 and a=0.05).
Changes from pre-to post-test were assessed using paired t-tests and the Wilcoxon signed rank test where appropriate; t-tests, ordinal logistic and binary logistic regression compared post-test measures by group. All analyses were "intention to treat".
Subgroup analysis
Interaction terms were calculated to test whether the effect of the EB booklet on outcomes was modi ed by men's preferences for decisional control.
RESULTS
Of the 392 men meeting our inclusion criteria, 258 consented to participate (65.8%). Consenting and nonconsenting men were of similar age (54.2 vs 53.8 years) (t 392 =0.44, p=0.66).
Ten men (4%) were excluded ( ve from each group) as their ages were outside the required range or because they had prostate cancer. The nal sample of 248 men comprised 126 who were given the EB booklet and 122 who were given the government pamphlet. Follow-up rates were similar between groups (n=106, 84%, for the EB booklet group; and n=108, 89%, for the pamphlet group) (c 2 (1) =1.01, p=0.31). Pre-test characteristics were equivalent between groups ( Table 1) . Table 2 summarises our results. Compared with men receiving the government pamphlet, men receiving the EB booklet were signi cantly more likely to give a correct estimate of the lifetime risk of developing and dying from prostate cancer (p<0.001). They were also less worried about dying from prostate cancer, although this comparison was not statistically signi cant (p=0.058).
Group comparisons
Knowledge scores signi cantly increased at post-test compared with pre-test for both groups (p<0.001). Post-test scores were signi cantly higher among men receiving the EB booklet than those receiving the government pamphlet, although the difference was small (p=0.049).
At post-test, the men's views were signi cantly less weighted than at pre-test towards reasons in favour of having PSA testing among men in both groups (p<0.001).
Post-test attitude scores for men receiving the government pamphlet were less weighted towards reasons for testing compared with those receiving the EB booklet (p=0.056).
Interest in PSA screening was similar between groups at post-test (p=0.93), although fewer men reported being "de nitely interested" in having a screening PSA test compared with pre-test (54% vs 24%; p<0.001).
At post-test, mean scores on the Decisional Uncertainty subscale were the same in the two groups (p=0.93). However, men receiving the EB booklet had signi cantly lower con ict scores on the Factors Contributing to Uncertainty subscale (p<0.001) and were more likely to agree that they could make an informed choice about PSA screening (p=0.008).
Subgroup analysis
The effect of the EB booklet on the outcomes did not signicantly differ according to men's preferences for involvement in medical decision-making (p=0.18-0.97).
Acceptability of the EB booklet
Over 75% of men receiving the EB booklet judged the information about the risks and bene ts of PSA screening as "about right", compared with just over half of those receiving the pamphlet (p<0.001) ( Table 3 ).
DISCUSSION
Compared with the non-numerical government literature, the EB booklet about PSA screening signi cantly improved men's knowledge of the potential bene t and harm of screening, yet did not appear to induce negative reactions. Our EB booklet reduced decisional con ict and did not increase worry about prostate cancer, despite the controversial state of the evidence.
Information about PSA screening should not be evaluated on the basis of whether men decide to have a test or not, as there is no "right" decision. 27 Hence, accurate knowledge and the clari cation of one's own values are fundamental to making the right decision when the evidence itself is not clear. 9 Our results indicate that an EB booklet achieves a positive experience of decision-making about PSA screening. It is reassuring to note that more information does not overwhelm men. Further, we found no evidence that patients who indicated a preference to adopt a "passive" role in decision-making were adversely affected by receiving comprehensive information that reinforced the principle of patient autonomy.
Despite being over three times the length of the government pamphlet, the EB booklet was just as likely to have been read in full. It was also considered "balanced" in presenting the pros and cons. Around 80% of men receiving the EB booklet considered the information it contained about the risks and bene ts of PSA screening to be "about right". As gaps in knowledge remained in both groups at post-test, we recommend further research to evaluate GP support of patient decision-making.
Medical authorities in the UK advise that "PSA tests . . . should only be offered after full counselling and provision of information". 3 This sentiment is endorsed by Australian and American organisations. 1,2 Thus, we need effective and acceptable resources with which to communicate the controversies and complexities of testing. As PSA testing is a personal decision involving trade-offs, the single best choice cannot be predetermined, since an optimal decision will be sensitive to and derived from an individual's own values. In conclusion, comprehensive evidence-based information, to which only experts and health professionals previously have been privy, achieves informed choice about PSA screening without raising alarm. Indeed, men who received it exhibited greater resolution about such a decision. Government literature might seek to be nonconfrontational in an effort to appease interests other than those of the consumer, but it may then tend to "gloss over" 28 the risks and uncertainties. Numerical, evidence-based information is necessary to empower men to make an informed decision.
